Pet Supplement Market Size, Share, Growth, and Industry Analysis, By Type (Multivitamins,Skin & Coat,Hip & Joint,Prebiotics & Probiotics,Calming), By Application (Dog,Cat,Freshwater Fish,Others), Regional Insights and Forecast to 2035
Pet Supplement Market Overview
The global Pet Supplement Market in terms of revenue was estimated to be worth USD 1416.93 Million in 2026 and is poised to reach USD 3008.61 Million by 2035, growing at a CAGR of 8.73% from 2026 to 2035.
The global pet supplement Market is witnessing significant growth driven by a rise in pet ownership, increased humanization of pets, and growing awareness about pet health. In 2024, over 62.7% of pet owners globally stated they provide supplements to their pets regularly. More than 39.2 million U.S. households owned cats, while 65.1 million owned dogs, with a rising inclination toward preventive healthcare. Supplements targeting hip & joint pain were among the most frequently used, accounting for over 31.6% usage in aging pets. The pet supplement Market report highlights that demand for multivitamins rose by 27.5% in the last three years.
In the USA, the pet supplement Market remains dominant, accounting for 41.3% of global consumption in 2024. Over 84.9 million U.S. households own at least one pet, fueling demand for pet nutrition enhancement. Sales of calming supplements for dogs increased by 22.6% year-over-year due to heightened pet anxiety issues. Hip & joint formulations comprised 38.2% of the U.S. market share, largely driven by aging dog populations. Cat-specific supplements grew by 19.8%, especially in multivitamins and coat health categories. The USA pet supplement Market analysis shows continued innovation and premiumization trends across product lines.
Key Findings
- Key Market Driver: 2% of pet owners prioritize nutritional supplements to prevent chronic diseases and promote overall wellness.
- Major Market Restraint: 6% of pet owners remain skeptical about supplement efficacy due to limited regulatory oversight and clinical validation.
- Emerging Trends: 5% growth in plant-based and organic pet supplements reflects changing consumer preferences toward natural ingredients.
- Regional Leadership: North America held 41.3% of the global pet supplement market share in 2024, followed by Europe with 25.4%.
- Competitive Landscape: Top five companies control 52.7% of the pet supplement market share, with Nutramax and Nestle S.A. leading.
- Market Segmentation: Multivitamins lead the product category with 32.8% share, while dogs dominate application share with 59.2%.
- Recent Development:1% of new product launches between 2023–2025 included prebiotics, probiotics, and calming formulations.
Pet Supplement Market Latest Trends
The pet supplement Market trends show a definitive shift toward holistic wellness and functional nutrition. In 2024, over 53.7% of pet owners expressed willingness to pay more for high-quality supplements. Multivitamin sales grew by 29.3% due to rising pet aging concerns and preventive health care measures. Calming supplements recorded a 22.4% spike, particularly in the U.S. and Europe, due to increased awareness about pet stress and separation anxiety. Fish oil and omega-based products for skin & coat health grew 18.9% year-on-year. The market for prebiotics and probiotics expanded by 34.2%, reflecting demand for gut health management.
Pet Supplement Market Dynamics
DRIVER
"Rising demand for pet health and preventive wellness care."
Increased awareness about pet health has become a critical growth driver for the pet supplement market market. In 2024, over 67.4% of pet owners stated that supplements were integral to their pet’s daily routine. Rising cases of pet obesity and arthritis have pushed the usage of joint and mobility supplements, which grew by 31.2% in the last two years. The growth in pet insurance policies—up 23.7% year-over-year—reflects the rising emphasis on proactive pet health care. Preventive supplements, particularly multivitamins and digestive aids, saw a usage rise of 28.5%. Online recommendations and veterinarian endorsements accounted for 45.9% of first-time supplement purchases.
RESTRAINT
"Limited clinical validation and regulatory clarity."
The absence of standardized regulations continues to restrain the pet supplement market market. Around 48.6% of consumers reported skepticism regarding the effectiveness of pet supplements. Additionally, 41.7% of veterinarians expressed concern over the lack of third-party testing. The presence of misleading labels—reported by 22.3% of products analyzed adds to the confusion. Many local or private label brands lack sufficient research, which affects their credibility. Moreover, only 17.4% of countries have clear frameworks governing pet supplements, creating inconsistencies in global trade. This limits large-scale adoption, especially in regions with stringent import norms and quality checks.
OPPORTUNITY
"Personalized pet supplements and breed-specific formulations."
Personalization is a key opportunity in the pet supplement market market. Breed-specific supplements accounted for 12.9% of newly launched products in 2024, up from 6.3% in 2022. DNA-based testing to determine nutritional deficiencies in pets rose by 27.1%, facilitating targeted supplementation. Custom-formulated supplements for senior pets, puppies, or high-energy breeds are gaining traction. Additionally, 36.4% of manufacturers have begun R&D on AI-powered recommendation tools to create customized supplement regimens. Pet supplement Market insights highlight a strong alignment with the broader pet wellness and humanization trend, with nearly 51.8% of owners expecting human-grade ingredient quality.
CHALLENGE
"Rising costs and premium pricing barriers."
Price sensitivity is a growing challenge in the pet supplement market market. Over 42.6% of pet owners consider supplements too expensive for daily use. Premium products, especially those with organic or rare botanical ingredients, are priced 35.2% higher than standard formulations. Raw material costs for ingredients like glucosamine, omega oils, and probiotics increased by 17.8% over two years. Transport and regulatory compliance costs, especially for imported brands, rose by 19.5%. Even though consumer demand is increasing, price remains a significant limiting factor for mass adoption, especially in developing economies where affordability dictates purchase behavior.
Pet Supplement Market Segmentation
The pet supplement Market is segmented by type and application. Product segmentation covers multivitamins, skin & coat, hip & joint, prebiotics & probiotics, and calming formulations. Application segmentation includes dogs, cats, freshwater fish, and others. In 2024, dogs accounted for 59.2% of the application market, while multivitamins held 32.8% of the product segment. Prebiotics & probiotics grew the fastest at 34.2%. Cat-focused supplements represented 21.5% of total applications. Segmentation data from the pet supplement market industry analysis shows rising specialization across both segments.
BY TYPE
Multivitamins: Multivitamins dominate with 32.8% share due to their broad utility. Over 49.7% of pet owners administer multivitamins daily, especially for senior pets. Vitamin B12, A, D, and E-based formulations lead this category. Demand increased by 27.5% year-on-year, especially in the USA and Europe. Brands are offering chewable, soft-gel, and liquid formats to improve administration. Multivitamins with dual benefits (e.g., immunity + digestion) now make up 38.2% of launches.
Multivitamins in the Pet Supplement Market are projected to reach USD 922.71 million by 2034, holding 33.3% of the market share with an estimated CAGR of 8.41% during the forecast period.
Top 5 Major Dominant Countries in the Multivitamins Segment
- United States: Expected to reach USD 311.82 million by 2034, capturing 33.8% market share with a CAGR of 7.94%, leading due to high pet healthcare spending.
- Germany: Forecasted to attain USD 81.21 million by 2034, holding 8.8% share with a CAGR of 8.52%, driven by aging pet population.
- Japan: Estimated at USD 65.34 million by 2034 with 7.1% share and 9.12% CAGR due to growing pet humanization trend.
- France: Projected to hit USD 58.76 million by 2034 with 6.3% share and 8.79% CAGR, supported by strong vet-based supplement adoption.
- India: Set to reach USD 52.61 million by 2034, contributing 5.7% share and growing at a high CAGR of 11.28% due to rising urban pet ownership.
Skin & Coat: Skin & coat supplements account for 18.6% of the market, with fish oil, biotin, and flaxseed-based ingredients leading. Omega-3 formulations witnessed a 19.4% growth in 2024. Pets with allergies and dull coats represent the major user base. Veterinarians recommend these for 22.1% of skin-related conditions. Demand among cats rose by 17.3%, especially in urban households.
Skin & Coat supplements are projected to achieve USD 487.46 million by 2034, with a 17.6% market share and a CAGR of 7.93% owing to increased demand for Omega-3 and dermatological care.
Top 5 Major Dominant Countries in the Skin & Coat Segment
- United States: Anticipated to hit USD 174.64 million by 2034, leading with 35.8% share and a 7.42% CAGR due to coat health concerns in aging pets.
- United Kingdom: Estimated at USD 48.26 million by 2034, capturing 9.9% share and a CAGR of 8.15% due to increased awareness about pet skin conditions.
- Canada: Forecasted at USD 45.13 million by 2034, holding 9.2% share with a 7.83% CAGR due to rising product availability in retail channels.
- Australia: Expected to reach USD 41.38 million by 2034, claiming 8.5% share with a CAGR of 8.94%, fueled by demand for natural supplements.
- South Korea: Set to hit USD 38.91 million by 2034, representing 8.0% share with a CAGR of 9.72% owing to expanding premium product lines.
Hip & Joint: Hip & joint supplements represent 25.2% of the product segment, driven by senior pets and large breeds. Glucosamine and chondroitin-based products increased in demand by 31.2%. Soft chews account for 44.8% of this subcategory. Formulations that combine anti-inflammatory herbs like turmeric grew by 23.6%. Hip & joint supplements are particularly popular in the USA and Germany.
Hip & Joint supplements are projected to reach USD 638.88 million by 2034, capturing 23.1% market share with an 8.54% CAGR driven by rising cases of pet arthritis and mobility concerns.
Top 5 Major Dominant Countries in the Hip & Joint Segment
- United States: Expected to top USD 241.77 million by 2034 with 37.8% share and a CAGR of 8.12% due to senior dog population growth.
- Germany: Forecasted at USD 59.26 million by 2034, accounting for 9.2% share with an 8.45% CAGR due to large dog breed demand.
- Brazil: Projected to hit USD 51.13 million by 2034, representing 8.0% share with an 8.97% CAGR from increased vet-based treatment.
- China: Expected to reach USD 48.86 million by 2034, accounting for 7.6% share with a CAGR of 9.88% amid aging pets.
- Italy: Estimated at USD 46.54 million by 2034, holding 7.3% share and growing at a CAGR of 8.67%.
Prebiotics & Probiotics: Prebiotics & probiotics now hold 15.4% market share, rising as digestive health gains focus. These supplements saw a 34.2% spike in 2024 alone. Around 37.5% of pet owners use digestive aids post-antibiotic treatments. Multi-strain probiotics and synbiotic formulations now comprise 28.3% of new product lines. Freeze-dried delivery formats improved shelf-life by 16.7%.
Prebiotics & Probiotics are set to grow to USD 429.48 million by 2034, holding 15.5% market share and showing the highest CAGR among all types at 9.64%, driven by rising digestive health focus.
Top 5 Major Dominant Countries in the Prebiotics & Probiotics Segment
- United States: Forecasted to achieve USD 148.73 million by 2034 with 34.6% share and a CAGR of 9.18%.
- India: Estimated at USD 56.32 million by 2034, contributing 13.1% share with a leading CAGR of 11.96%.
- Japan: Projected at USD 48.91 million by 2034, holding 11.4% share and growing at 10.42% CAGR.
- Germany: Set to reach USD 42.14 million by 2034 with 9.8% share and a CAGR of 8.96%.
- Mexico: Expected to attain USD 39.83 million by 2034 with 9.3% share and a CAGR of 10.13%.
Calming: Calming supplements constitute 8.0% of the market, with melatonin, valerian root, and hemp extract-based products increasing by 22.4%. Separation anxiety, travel stress, and loud noise sensitivity are key triggers. 29.1% of new product innovations in this space target dogs under two years. Gummies and flavored treats dominate the format with 62.8% share.
Calming supplements will grow to USD 288.51 million by 2034, making up 10.4% of the market with an 8.36% CAGR as anxiety-related pet health issues increase globally.
Top 5 Major Dominant Countries in the Calming Segment
- United States: Anticipated at USD 105.62 million by 2034, with 36.6% share and a CAGR of 7.94%.
- France: Projected to hit USD 41.57 million by 2034 with 14.4% share and an 8.89% CAGR.
- Australia: Estimated at USD 38.32 million by 2034, holding 13.3% share and growing at a 9.12% CAGR.
- Canada: Forecasted at USD 36.91 million by 2034, making up 12.8% share and showing a CAGR of 8.44%.
- South Africa: Set to reach USD 33.62 million by 2034, with 11.7% share and a CAGR of 9.18%.
BY APPLICATION
Dog: Dogs represent 59.2% of total market usage. Large breeds and aging dogs are primary consumers of hip & joint and multivitamin supplements. Over 44.3% of owners report giving supplements daily. Formulations focused on immunity and coat health account for 37.6% of total dog-specific SKUs. The USA and Germany are key markets.
The dog application is projected to reach USD 1663.74 million by 2034, dominating with a 60.1% market share and an 8.29% CAGR due to higher supplement usage among senior and large-breed dogs.
Top 5 Major Dominant Countries in the Dog Application
- United States: Expected at USD 596.44 million by 2034 with 35.8% share and a CAGR of 7.91%.
- Germany: Projected to reach USD 152.67 million by 2034, accounting for 9.2% share and an 8.45% CAGR.
- India: Estimated at USD 145.81 million by 2034, holding 8.8% share and growing at 10.91% CAGR.
- Brazil: Set to hit USD 139.24 million by 2034, representing 8.4% share and an 8.78% CAGR.
- France: Forecasted at USD 128.36 million by 2034, comprising 7.7% share with a CAGR of 8.36%.
Cat: Cats hold 21.5% market share, with demand for multivitamins and hairball control supplements growing 19.8% annually. Skin & coat supplements with omega-3 and vitamin E are preferred. 26.7% of owners reported using supplements during post-surgery recovery. New launches often come in soft gel capsules and treat formats.
The cat segment is projected to reach USD 662.18 million by 2034, making up 23.9% market share and a CAGR of 9.13% driven by digestive, coat, and calming supplement preferences.
Top 5 Major Dominant Countries in the Cat Application
- United States: Estimated at USD 242.61 million by 2034, accounting for 36.6% share and 8.64% CAGR.
- Japan: Forecasted to hit USD 81.28 million by 2034, holding 12.2% share with a CAGR of 9.76%.
- Germany: Set to reach USD 74.15 million by 2034, with 11.2% share and 9.14% CAGR.
- France: Projected at USD 69.34 million by 2034, contributing 10.5% share with 8.88% CAGR.
- Australia: Estimated at USD 63.41 million by 2034 with 9.6% share and 9.22% CAGR.
Freshwater Fish: Freshwater fish applications account for 10.4% share. Supplements for enhancing coloration and fin growth rose by 14.6%. Prebiotics and probiotics are common to manage waterborne infections and gut health. 35.9% of products are administered via tank infusions. Algae-based immunity boosters saw 12.3% growth.
The freshwater fish segment will hit USD 267.45 million by 2034, holding 9.7% market share and a CAGR of 9.01% due to rising ornamental fish care trends.
Top 5 Major Dominant Countries in the Freshwater Fish Application
- Japan: Expected to reach USD 89.47 million by 2034 with 33.4% share and 9.62% CAGR.
- China: Estimated at USD 61.22 million by 2034, capturing 22.9% share and a CAGR of 9.97%.
- India: Projected to hit USD 45.81 million by 2034 with 17.1% share and an 11.31% CAGR.
- United States: Forecasted at USD 39.74 million by 2034, holding 14.9% share and growing at 8.28% CAGR.
- Thailand: Anticipated at USD 31.21 million by 2034 with 11.7% share and 10.18% CAGR.
Others (Birds, Reptiles, etc.): This segment holds 8.9% share, with birds and reptiles leading. Calcium and vitamin D3 supplements for reptiles grew by 16.2%. Avian feather care supplements recorded 11.4% growth. Powdered forms dominate, with 43.7% usage reported among exotic pet owners.
The “Others” application is projected to reach USD 173.67 million by 2034, capturing 6.3% market share and growing at a CAGR of 8.77% due to increasing supplement use in birds and reptiles.
Top 5 Major Dominant Countries in the Others Application
- United States: Estimated at USD 64.27 million by 2034 with 37.0% share and a CAGR of 8.23%.
- Germany: Projected to hit USD 31.14 million by 2034, accounting for 17.9% share and 8.94% CAGR.
- South Africa: Forecasted at USD 28.69 million by 2034, contributing 16.5% share and a CAGR of 9.38%.
- Brazil: Expected at USD 26.41 million by 2034, representing 15.2% share with an 8.66% CAGR.
- Italy: Estimated at USD 23.16 million by 2034 with 13.3% share and 8.52% CAGR.
Pet Supplement Market Regional Outlook
The global pet supplement Market demonstrates robust regional diversity. North America held 41.3% of the market share in 2024 due to high pet ownership and premium product demand. Europe followed with a 25.4% market share, driven by rising awareness and veterinary involvement. Asia-Pacific captured 22.8% market share, fueled by urbanization and increasing disposable income. The Middle East & Africa accounted for 10.5%, supported by a growing companion animal trend. Each region shows distinct preferences in product type, with calming supplements trending in North America, probiotics in Asia-Pacific, and skin & coat solutions dominating the European market.
North America
North America remains the largest contributor to the global pet supplement Market with a 41.3% share. The USA alone accounts for 82.6% of the North American market. As of 2024, 65.1 million households own dogs, and 39.2 million own cats in the USA. Among them, 62.7% use supplements regularly. Hip & joint formulations make up 38.2% of pet supplement sales in this region. Calming supplements rose 22.6% in demand in the past year, especially due to increased remote work and pet stress. The market is led by companies like Nutramax Laboratories and Nestlé Purina. Online channels account for 61.8% of sales in this region.
North America is projected to dominate the pet supplement market by reaching USD 1172.84 million by 2034, holding a commanding 42.37% market share and achieving a CAGR of 8.56%, driven by high disposable income and premium pet healthcare focus.
North America - Major Dominant Countries in the “Pet Supplement Market Market”
- United States – Estimated to lead with USD 1014.73 million by 2034, contributing 86.49% of regional share and expanding at a CAGR of 8.65%, backed by advanced veterinary channels and strong pet ownership culture.
- Canada – Forecast to reach USD 96.32 million by 2034, representing 8.21% share of the regional market and a CAGR of 8.42%, fueled by growth in pet wellness trends.
- Mexico – Expected to hit USD 45.31 million by 2034, covering 3.86% regional share with a CAGR of 8.78%, driven by rising awareness of pet nutritional needs.
- Puerto Rico – Anticipated to reach USD 9.87 million by 2034, accounting for 0.84% market share and posting a CAGR of 7.96%, influenced by growing local pet stores.
- Dominican Republic – Projected to grow to USD 6.61 million by 2034, comprising 0.56% regional share and 8.12% CAGR, with increasing pet care product accessibility.
Europe
Europe holds 25.4% of the global pet supplement Market share. Germany, the UK, and France are key contributors. In 2024, 23.8% of pet owners in Europe administered supplements daily. Demand for omega-rich supplements grew 18.3%, especially in the skin & coat segment. Regulatory involvement increased, with 19.6% of new products tested for EFSA compliance. Vegan and organic formulations saw 24.7% year-over-year growth. Multivitamins and calming products made up 41.1% of online pet health sales. The region saw a 15.9% increase in subscription-based pet supplement services between 2023 and 2024.
Europe is anticipated to grow significantly in the pet supplement market, reaching USD 688.27 million by 2034, representing 24.87% share and expanding at a CAGR of 8.34% amid rising trend of pet humanization and preventive care.
Europe - Major Dominant Countries in the “Pet Supplement Market Market”
- Germany – Forecast to dominate with USD 189.56 million by 2034, holding 27.54% of Europe’s share and a CAGR of 8.19% due to increasing veterinary supplement sales.
- France – Estimated to reach USD 142.84 million by 2034, capturing 20.75% share with a CAGR of 8.42%, driven by pet-specific health product launches.
- United Kingdom – Expected to post USD 122.47 million by 2034, accounting for 17.79% regional share and CAGR of 8.63%, due to demand in premium supplements.
- Italy – Projected to hit USD 113.68 million by 2034, with 16.51% share and 8.14% CAGR, driven by aging pet population trends.
- Spain – Anticipated to reach USD 96.72 million by 2034, representing 14.05% share and growing at 8.73% CAGR due to rising interest in natural pet supplements.
Asia-Pacific
Asia-Pacific captured 22.8% market share in 2024, showing the fastest growth. China and India are major drivers, with urban pet ownership rising by 17.3%. In Japan, 34.5% of pet owners use supplements for immunity and gut health. Probiotics and prebiotics grew 29.2% in demand across the region. Regional brands are focusing on herbal and Ayurvedic ingredients, with 19.4% of Indian products incorporating traditional medicine elements. Online retail grew 38.5% year-on-year. Premiumization is rising, with a 26.1% surge in demand for tailored, breed-specific formulations. The Asia-Pacific pet supplement market outlook shows strong investment potential.
Asia’s pet supplement market is projected to reach USD 514.63 million by 2034, commanding 18.59% market share with a CAGR of 9.27%, driven by rapid urbanization and rising pet ownership across major economies.
Asia - Major Dominant Countries in the “Pet Supplement Market Market”
- China – Expected to dominate with USD 168.47 million by 2034, contributing 32.74% of Asia’s share and registering a CAGR of 9.65%, supported by increased spending on premium pet nutrition.
- India – Forecast to grow to USD 121.95 million by 2034, making up 23.69% share and experiencing the highest CAGR of 9.88%, driven by booming pet wellness demand.
- Japan – Projected to reach USD 97.53 million by 2034, accounting for 18.95% of regional share and 8.89% CAGR, with supplements tailored to aging pets.
- South Korea – Estimated to reach USD 76.32 million by 2034, covering 14.83% share and showing a CAGR of 8.96% as premium segment adoption grows.
- Thailand – Expected to hit USD 50.36 million by 2034, contributing 9.78% of market share with a CAGR of 9.21%, driven by rising retail availability.
Middle East & Africa
Middle East & Africa hold 10.5% of the pet supplement Market share. South Africa and the UAE lead regional adoption, with rising companion pet ownership and pet humanization trends. Supplement demand increased by 18.9% in 2024. Calcium and multivitamin products are commonly used, making up 47.6% of total consumption. Import dependence remains high, with 71.4% of products sourced from North America or Europe. E-commerce platforms saw a 33.8% rise in pet supplement sales. Market growth is driven by increased vet care access, which rose by 21.2% across major cities.
The Middle East and Africa pet supplement market is projected to reach USD 391.30 million by 2034, with 14.14% global share and CAGR of 8.02%, fueled by increasing urban pet ownership and emerging vet infrastructure.
Middle East and Africa - Major Dominant Countries in the “Pet Supplement Market Market”
- South Africa – Forecast to lead with USD 127.54 million by 2034, holding 32.60% share and growing at 8.11% CAGR due to increasing demand for pet nutrition products.
- United Arab Emirates – Projected to hit USD 95.87 million by 2034, contributing 24.50% regional share with a CAGR of 8.39%, driven by premium product imports.
- Saudi Arabia – Expected to reach USD 81.22 million by 2034, capturing 20.75% share and CAGR of 7.94% as urban pet ownership rises.
- Israel – Anticipated to grow to USD 52.68 million by 2034, representing 13.46% of market and an 8.01% CAGR, aided by increased availability of vet services.
- Egypt – Forecast to reach USD 34.00 million by 2034, comprising 8.69% regional share and posting 7.81% CAGR due to rising awareness in pet dietary needs.
List of Top Pet Supplement Market Companies
- Novotech Nutraceuticals, Inc.
- Food Science Corporation
- Bayer AG
- Zoetis Inc.
- Kemin Industries
- Ark Naturals Company
- Virbac
- Now Health Group, Inc.
- Nestlé S.A.
- Nutramax Laboratories, Inc.
Top 2 Companies with Highest Market Share:
Nutramax Laboratories, Inc.: Nutramax Laboratories holds the highest market share at 18.4%. The company dominates the hip & joint and digestive health segments, with its flagship products used by over 26.5 million pets globally. Its U.S. presence spans over 75,000 veterinary clinics.
Nestlé S.A.: Nestlé S.A. commands 16.2% market share through its Purina division. The company leads in multivitamin and calming formulations. In 2024, Nestlé launched over 42 new SKUs focused on natural and functional ingredients for dogs and cats.
Investment Analysis and Opportunities
The pet supplement Market is attracting strong B2B investment. In 2024, private equity investments in pet wellness reached $2.1 billion globally. Over 38.6% of funding rounds went to startups offering personalized pet nutrition. Manufacturers invested 23.4% more in R&D compared to the previous year, focusing on ingredient innovation and delivery formats. Expansion into Asia-Pacific is on the rise, with 31.8% of investments directed to that region. Franchise-based veterinary supplement stores grew by 14.6% in 2024. Strategic partnerships between pharmaceutical companies and pet supplement brands increased by 17.9%. Co-manufacturing agreements allow small players to scale. Demand for pet supplement Market insights is rising, with 42.3% of industry leaders prioritizing market intelligence tools. Governments and trade associations are offering incentives for organic product development, especially in North America and Europe.
New Product Development
New product development in the pet supplement Market is focused on clean labels, innovative delivery systems, and natural ingredients. In 2024, over 63.5% of newly launched supplements featured plant-based components. Soft chews and palatable treat formats accounted for 47.9% of launches. Water-soluble powders for fish and reptiles rose by 12.4% in volume. Functional innovation is driving demand, with 28.6% of products combining joint support with immunity benefits. Hemp-infused calming treats grew by 19.7%. AI-driven customization apps, now used by 21.3% of supplement brands, allow pet owners to tailor formulations based on pet age, weight, and breed. Liquid multivitamins in squeeze tubes gained 14.2% popularity for ease of use.
Five Recent Developments
- 2023: Nutramax Laboratories launched a triple-action probiotic + fiber + vitamin blend that increased digestive supplement sales by 18.3%.
- 2024: Zoetis Inc. introduced breed-specific calming chews for small dog breeds, boosting sales by 14.6% within the first quarter.
- 2024: Nestlé S.A. added 20 new organic supplement products under its Purina brand, contributing to a 21.8% growth in online category sales.
- 2025: Bayer AG expanded its pet health R&D unit, allocating 27.5% more budget to herbal and hemp-based formulations.
- 2025: Food Science Corporation partnered with vet clinics across 1,500 U.S. cities to co-market its probiotic supplements.
Report Coverage
The Pet Supplement Market Report provides a comprehensive overview of industry dynamics, growth segments, regional performance, and competitive strategies. It covers market data from 2021 to 2025, with forecasts extending to 2034. The report includes 27+ data tables and 45+ charts reflecting trends and performance indicators. Over 100 companies were analyzed, with special focus on top 10 leaders. The report offers segmentation by type (multivitamins, hip & joint, calming, skin & coat, prebiotics & probiotics) and application (dogs, cats, freshwater fish, others). Market size estimates are presented in volume and units sold. The Pet Supplement Market Research Report also highlights consumer behavior patterns, regional demand cycles, and cross-border trade insights. It includes recent product launches, investment trends, and technological advancements shaping the industry. Coverage includes regulatory developments and their impact across key regions. The Pet Supplement Market Forecast section provides insights for investors and B2B manufacturers targeting growth.
Pet Supplement Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 1416.93 Million in 2026 |
|
|
Market Size Value By |
USD 3008.61 Million by 2035 |
|
|
Growth Rate |
CAGR of 8.73% from 2026-2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
The global Pet Supplement Market is expected to reach USD 3008.61 Million by 2035.
The Pet Supplement Market is expected to exhibit a CAGR of 8.73% by 2035.
Novotech Nutraceuticals, Inc.,Food Science Corporation,Bayer Ag,Zoetis Inc.,Kemin Industries.,Ark Naturals Company,Virbac,Now Health Group, Inc.,Nestle S. A.,Nutramax Laboratories, Inc..
In 2025, the Pet Supplement market value stood at USD 1303.16 Million.